Treatment of Vasomotor Symptoms in Korean Post Menopausal Women
Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
Study to demonstrate that the therapeutic efficacy of Angeliq® is better than placebo in
Korean postmenopausal women with hot flushes and other climacteric symptoms. Safety and
tolerability of Angeliq.